Taken together, the three selected miRNAs not only have the potential to serve as early biomarkers for detecting post-AMI AKI, but may also contribute to post-AMI AKI pathogenesis by regulating TGF-β signaling and apoptosis to promote renal injury and fibrosis. This evidence concerns the gene TGFB1 and acute kidney injury.